Aimed Bio Inc. (KOSDAQ:0009K0)
South Korea flag South Korea · Delayed Price · Currency is KRW
48,750
-100 (-0.20%)
At close: Apr 29, 2026

Aimed Bio Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22
3,029,8443,695,395---
Enterprise Value
2,860,1843,612,198---
Last Close Price
46850.0057600.00---
PE Ratio
603.25735.76---
PS Ratio
64.0978.16---
PB Ratio
15.7319.19---
P/TBV Ratio
15.8719.35---
P/FCF Ratio
173.07211.09---
P/OCF Ratio
169.64206.91---
EV/Sales Ratio
60.5076.40---
EV/EBITDA Ratio
129.12163.07---
EV/EBIT Ratio
137.72173.93---
EV/FCF Ratio
163.38206.34---
Debt / Equity Ratio
0.010.010.010.050.11
Debt / EBITDA Ratio
0.050.050.40--
Debt / FCF Ratio
0.070.07---
Net Debt / Equity Ratio
-0.88-0.88-0.78-0.98-0.53
Net Debt / EBITDA Ratio
-7.66-7.66-33.233.211.04
Net Debt / FCF Ratio
-9.69-9.696.884.991.15
Asset Turnover
0.380.380.340.01-
Quick Ratio
31.1731.1716.914.246.99
Current Ratio
31.4331.4317.024.257.13
Return on Equity (ROE)
4.23%4.23%-10.62%-66.75%-
Return on Assets (ROA)
10.55%10.55%-0.73%-24.04%-
Return on Capital Employed (ROCE)
10.70%10.70%-0.90%-35.60%-55.90%
Earnings Yield
0.17%0.14%---
FCF Yield
0.58%0.47%---
Buyback Yield / Dilution
-39.98%-39.98%-4.02%-2.16%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.